ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $150,822,429 | +7.3% | 3,816,357 | +9.1% | 0.04% | -2.7% |
| Q3 2022 | $140,533,729 | -1.5% | 3,497,604 | +3.1% | 0.04% | 0.0% |
| Q2 2022 | $142,662,614 | +19.2% | 3,393,497 | +10.5% | 0.04% | +42.3% |
| Q1 2022 | $119,661,588 | +1.4% | 3,071,396 | +3.8% | 0.03% | +8.3% |
| Q4 2021 | $117,966,000 | +14.1% | 2,960,240 | +3.5% | 0.02% | +4.3% |
| Q3 2021 | $103,387,000 | -9.8% | 2,860,730 | +2.4% | 0.02% | -8.0% |
| Q2 2021 | $114,565,000 | -4.9% | 2,794,952 | +1.2% | 0.02% | -10.7% |
| Q1 2021 | $120,528,000 | +135.5% | 2,763,137 | +170.2% | 0.03% | +133.3% |
| Q4 2020 | $51,180,000 | +68.4% | 1,022,571 | +41.6% | 0.01% | +50.0% |
| Q3 2020 | $30,390,000 | -72.8% | 722,363 | -68.6% | 0.01% | -75.0% |
| Q2 2020 | $111,787,000 | – | 2,302,508 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |